{"article":{"annotation":{"article_id":"sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation","available_at":"2026-10-25T10:05:39.383745Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"31142758b8b4a8e3cd915448bcfb860e99572003ac052dbbc00490516c359b3d","input_sha256":"0835e810a3598251a1047ac85ad3f4ebd932159d32c001ce327b0aaa80389ae9","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[{"admin1":null,"city":null,"coordinate_note":null,"coordinate_reference_system":"OGC:CRS84","coordinate_source":null,"country":"FR","evidence":[{"field":"country","language":"en","note":"Explicit preserved editorial country/region; no city or national centroid inferred","source_urls":["https://www.sartorius.com/en/company/newsroom/corporate-news/2026-nine-month-results-sartorius-stedim-biotech-1886542","https://www.sartorius.com/download/1886548/9m-2026-download-media-release-ssb-en-data.pdf"]}],"geometry":null,"id":"iso3166-1:FR","kind":"country-or-area","labels":{"ar":"فرنسا","en":"France","es":"Francia","fr":"France"},"match_status":"candidate","precision":"regional","role":"coverage","uncertainty_m":null}],"rules_sha256":"fb5ad3c27c91cb840f7a0a05f7f64a5cb26ad0374409ff9457f277c7092e22b4","schema_version":1,"subjects":[{"concept_id":"medtop:20000178","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: reports nine-month sales and profit","source_urls":["https://www.sartorius.com/en/company/newsroom/corporate-news/2026-nine-month-results-sartorius-stedim-biotech-1886542","https://www.sartorius.com/download/1886548/9m-2026-download-media-release-ssb-en-data.pdf"]}],"method":"controlled-rules-v1","rule_id":"corporate-results","status":"candidate"},{"concept_id":"medtop:13000000","confidence":null,"confidence_method":null,"evidence":[{"field":"category+topics","language":"en","note":"Preserved editorial category/topic; broad candidate only","source_urls":["https://www.sartorius.com/en/company/newsroom/corporate-news/2026-nine-month-results-sartorius-stedim-biotech-1886542","https://www.sartorius.com/download/1886548/9m-2026-download-media-release-ssb-en-data.pdf"]}],"method":"controlled-rules-v1","rule_id":"technology-broad","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation?lang=en","category":"technology","content":{"key_points":[],"paragraphs":["Sartorius Stedim Biotech reported sales revenue of €2.289 billion for the first nine months of 2026, up 4.3% as reported and 6.5% at constant currencies when customer tariff compensation is included. Excluding that compensation, operational sales growth at constant currencies was 7.8%. The company said recurring consumables remained the main growth driver, while bioprocess equipment also expanded.","The compensation affected how revenue was recorded. During the third quarter, Sartorius Stedim received refunds for U.S. levies invalidated by the Supreme Court and passed related tariff surcharges back to customers. The €28 million compensation after nine months was recognized as a reduction in sales revenue and cost of sales. With the surcharge and refund offsetting on a net basis, the company said they did not affect profitability.","Regional sales also grew at constant exchange rates. EMEA revenue was €982 million, up 6.5%; the Americas generated €783 million, growing 7.6% excluding customer compensation and 3.9% including it; Asia-Pacific rose 10.6% to €524 million, with China contributing positively. The Americas comparison was particularly affected by tariff compensation, so the two growth rates describe different revenue bases.","Underlying EBITDA increased 4.8% to €716 million, and its margin rose from 31.1% to 31.3%. Sartorius Stedim attributed the improvement to positive volume effects and economies of scale more than offsetting product mix. Net profit rose 26.7% to €277 million; underlying net profit increased 9.4% to €350 million. These underlying measures are company-defined alternatives to standard financial measures.","Cash generation strengthened: operating cash flow advanced 11.6% to €498 million and free cash flow rose 58.5% to €264 million. The company linked operating cash flow to earnings and tariff refunds; lower investment spending also supported free cash flow. Capital expenditure was €232 million, or 10.1% of sales, compared with €276 million and 12.6% a year earlier. Net debt was €2.138 billion, with net debt to underlying EBITDA at 2.26.","The company reported 10,483 employees at 30 September, up from 10,265 at the end of 2025. It also introduced an improved single-use bioreactor bag designed to increase oxygen transfer, and added ready-to-use cytokines in closed sterile bags and an animal-component-free cell-culture medium for advanced therapies. These launches broaden the portfolio in bioprocessing and cell and gene therapy manufacturing.","Sartorius Stedim confirmed its full-year 2026 sales and profitability guidance and refined its capital-spending ratio. Revenue growth at constant currencies is expected at 6% to 10%; operational growth excluding tariff effects is expected near the midpoint, while growth including planned customer compensation is expected in the lower half. Compensation could reduce revenue by up to €35 million against initial assumptions. The underlying EBITDA margin is expected to be slightly above 31%.","Capital expenditure is now projected at around 13% of revenue, and the net-debt-to-underlying-EBITDA ratio is expected to fall to slightly above 2. Management said forecasts use constant currencies and noted greater industry, geopolitical and trade-policy uncertainty. The figures cover nine months ending 30 September and include alternative performance measures; the company says these measures are not defined by international accounting standards and its release was unaudited."],"sections":[]},"corrections":[],"country":"FR","data":{"blocks":[{"description":{"ar":"الإيرادات وتعويض العملاء المرتبط بالرسوم والربحية وتوقعات 2026.","de":"Umsatz, zollbedingte Kundenerstattung, Profitabilität und Ausblick 2026.","en":"Revenue, tariff-related customer compensation, profitability and 2026 guidance.","es":"Ingresos, compensación arancelaria a clientes, rentabilidad y previsiones 2026.","fr":"Chiffre d’affaires, compensations tarifaires aux clients, rentabilité et perspectives 2026.","pt":"Receitas, compensação tarifária a clientes, rentabilidade e perspetivas 2026.","tr":"Gelir, tarifelerle ilgili müşteri telafisi, kârlılık ve 2026 hedefleri."},"id":"ssb-nine-month-sales-profit-and-guidance","items":[{"basis":"observed","label":{"ar":"إيرادات تسعة أشهر","de":"Neunmonatsumsatz","en":"Nine-month revenue","es":"Ingresos de nueve meses","fr":"Chiffre d’affaires sur neuf mois","pt":"Receitas de nove meses","tr":"Dokuz aylık gelir"},"measure":{"aggregation":"flow","frequency":"irregular","geography":"world","id":"ssb-nine-month-revenue-2026","periodRole":"reference-period","unitCode":"million-eur"},"period":"2026-09","unit":"million EUR","value":2289.2,"valueQualifier":"exact"},{"basis":"observed","label":{"ar":"نمو الإيرادات التشغيلية بأسعار ثابتة","de":"Operatives Umsatzwachstum bei konstanten Wechselkursen","en":"Operational sales growth at constant currencies","es":"Crecimiento operativo a tipos constantes","fr":"Croissance opérationnelle à changes constants","pt":"Crescimento operacional a câmbios constantes","tr":"Sabit kurda operasyonel gelir büyümesi"},"measure":{"aggregation":"change","frequency":"irregular","geography":"world","id":"ssb-nine-month-operational-growth-cc","periodRole":"reference-period","unitCode":"percent"},"period":"2026-09","unit":"percent","value":7.8,"valueQualifier":"exact"},{"basis":"observed","label":{"ar":"نمو الإيرادات شاملاً تعويض الرسوم، بسعر ثابت","de":"Umsatzwachstum einschließlich Zollkompensation, konstant","en":"Revenue growth including tariff compensation, constant currency","es":"Crecimiento con compensación arancelaria, tipos constantes","fr":"Croissance avec compensation tarifaire, à changes constants","pt":"Crescimento com compensação tarifária, câmbio constante","tr":"Tarife telafileri sonrası gelir büyümesi, sabit kur"},"measure":{"aggregation":"change","frequency":"irregular","geography":"world","id":"ssb-nine-month-growth-with-compensation-cc","periodRole":"reference-period","unitCode":"percent"},"period":"2026-09","unit":"percent","value":6.5,"valueQualifier":"exact"},{"basis":"observed","label":{"ar":"EBITDA الأساسية","de":"Bereinigtes EBITDA","en":"Underlying EBITDA","es":"EBITDA subyacente","fr":"EBITDA sous-jacent","pt":"EBITDA subjacente","tr":"Düzeltilmiş EBITDA"},"measure":{"aggregation":"flow","frequency":"irregular","geography":"world","id":"ssb-nine-month-underlying-ebitda","periodRole":"reference-period","unitCode":"million-eur"},"period":"2026-09","unit":"million EUR","value":716,"valueQualifier":"exact"},{"basis":"observed","label":{"ar":"التدفق النقدي الحر","de":"Free Cashflow","en":"Free cash flow","es":"Flujo de caja libre","fr":"Flux de trésorerie disponible","pt":"Fluxo de caixa livre","tr":"Serbest nakit akışı"},"measure":{"aggregation":"flow","frequency":"irregular","geography":"world","id":"ssb-nine-month-free-cash-flow","periodRole":"reference-period","unitCode":"million-eur"},"period":"2026-09","unit":"million EUR","value":264,"valueQualifier":"exact"},{"basis":"forecast","label":{"ar":"الحد الأدنى لنمو الإيرادات 2026 بسعر ثابت","de":"Untergrenze Umsatzwachstum 2026 konstant","en":"2026 constant-currency sales growth low end","es":"Límite inferior del crecimiento 2026 a tipos constantes","fr":"Borne basse de la croissance 2026 à changes constants","pt":"Limite inferior do crescimento 2026 a câmbios constantes","tr":"2026 sabit kurda gelir büyümesi alt sınırı"},"measure":{"aggregation":"rate","frequency":"annual","geography":"world","id":"ssb-2026-sales-growth-guidance-low","periodRole":"reference-period","unitCode":"percent"},"period":"2026","unit":"percent","value":6,"valueQualifier":"lower-bound"},{"basis":"forecast","label":{"ar":"الحد الأعلى لنمو الإيرادات 2026 بسعر ثابت","de":"Obergrenze Umsatzwachstum 2026 konstant","en":"2026 constant-currency sales growth high end","es":"Límite superior del crecimiento 2026 a tipos constantes","fr":"Borne haute de la croissance 2026 à changes constants","pt":"Limite superior do crescimento 2026 a câmbios constantes","tr":"2026 sabit kurda gelir büyümesi üst sınırı"},"measure":{"aggregation":"rate","frequency":"annual","geography":"world","id":"ssb-2026-sales-growth-guidance-high","periodRole":"reference-period","unitCode":"percent"},"period":"2026","unit":"percent","value":10,"valueQualifier":"upper-bound"},{"basis":"forecast","label":{"ar":"الحد الأعلى المحتمل للتعويض مقارنة بالافتراضات الأولية","de":"Mögliche Obergrenze der Kompensation gegenüber ursprünglicher Annahme","en":"Potential compensation ceiling vs initial assumptions","es":"Límite máximo potencial de compensación frente a supuestos iniciales","fr":"Plafond potentiel de compensation par rapport aux hypothèses initiales","pt":"Limite máximo potencial da compensação face às premissas iniciais","tr":"İlk varsayımlara kıyasla olası telafi üst sınırı"},"measure":{"aggregation":"flow","frequency":"annual","geography":"world","id":"ssb-customer-tariff-compensation-revenue-ceiling","periodRole":"reference-period","unitCode":"million-eur"},"period":"2026","unit":"million EUR","value":35,"valueQualifier":"upper-bound"}],"methodology":{"ar":"المبالغ المالية بملايين اليورو. النمو التشغيلي يستثني تعويض العملاء؛ والمقارنة الشاملة تميز النمو بسعر ثابت والمعلن. نطاق النمو السنوي توقع.","de":"Finanzbeträge in Millionen Euro. Operatives Wachstum schließt Kundenerstattungen aus; die inklusive Kennzahl trennt konstante Wechselkurse und berichtetes Wachstum. Die Jahresrate ist eine Prognose.","en":"Financial amounts are in millions of euros. Operational growth excludes customer compensation; the inclusive comparison separates constant-currency and reported growth. The full-year growth range is a forecast.","es":"Importes en millones de euros. El crecimiento operativo excluye compensaciones a clientes; la medida inclusiva distingue tipos constantes y cifras publicadas. El intervalo anual es una previsión.","fr":"Montants en millions d’euros. La croissance opérationnelle exclut la compensation client ; la mesure incluant celle-ci distingue changes constants et données publiées. La fourchette annuelle est une prévision.","pt":"Montantes financeiros em milhões de euros. O crescimento operacional exclui compensações a clientes; a medida inclusiva distingue câmbios constantes e valores reportados. O intervalo anual é uma previsão.","tr":"Gelir ve kâr tutarları milyon avrodur; operasyonel büyüme müşteri telafisi hariç, büyüme dahil ölçüm ise telafiler sonrası sabit kur ve bildirilen büyümeyi ayırır. Yıllık büyüme aralığı tahmindir."},"sourceUrls":["https://www.sartorius.com/en/company/newsroom/corporate-news/2026-nine-month-results-sartorius-stedim-biotech-1886542","https://www.sartorius.com/download/1886548/9m-2026-download-media-release-ssb-en-data.pdf"],"title":{"ar":"مؤشرات Sartorius Stedim المالية لتسعة أشهر","de":"Finanzkennzahlen von Sartorius Stedim für neun Monate","en":"Sartorius Stedim nine-month financial indicators","es":"Indicadores financieros de Sartorius Stedim en nueve meses","fr":"Indicateurs financiers de Sartorius Stedim sur neuf mois","pt":"Indicadores financeiros da Sartorius Stedim em nove meses","tr":"Sartorius Stedim dokuz aylık finansal göstergeleri"},"type":"metrics","updatedAt":"2026-10-25T08:56:51Z"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation/data/ssb-nine-month-sales-profit-and-guidance?lang=en&format=csv","json":"https://newsverum.com/api/v1/articles/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation/data/ssb-nine-month-sales-profit-and-guidance?lang=en&format=json"},"id":"ssb-nine-month-sales-profit-and-guidance"}],"data_types":["metrics"],"editorial_illustration":{"alt":"Conceptual illustration of technology, processors and connected information.","asset_id":"newsverum-v1-technology","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"en","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-1536.webp","width":1536}],"width":1536},"event_id":"event-a201a41e-71f9-52e9-8412-d8541a9d125b","event_period":"2026-09-30","event_period_basis":"event-or-reference-period","id":"sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation","image":null,"importance":0.6,"language":"en","modified_at":"2026-10-25T10:05:25+00:00","publication_basis":"publication-record","published_at":"2026-10-25T10:05:25+00:00","reading_minutes":3,"region":"world","section_illustration":{"alt":"Conceptual illustration of technology, processors and connected information.","asset_id":"newsverum-v1-technology","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"en","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/technology-1536.webp","width":1536}],"width":1536},"slug":"sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation","sources":[{"checkedAt":"2026-10-25","name":"Sartorius Stedim Biotech","publishedAt":"2026-10-22","url":"https://www.sartorius.com/en/company/newsroom/corporate-news/2026-nine-month-results-sartorius-stedim-biotech-1886542"},{"checkedAt":"2026-10-25","name":"Sartorius Stedim Biotech nine-month 2026 media release (PDF)","publishedAt":"2026-10-22","url":"https://www.sartorius.com/download/1886548/9m-2026-download-media-release-ssb-en-data.pdf"}],"summary":"The company separated tariff compensation and currency effects while confirming its 2026 guidance.","text":"The company separated tariff compensation and currency effects while confirming its 2026 guidance.\n\nSartorius Stedim Biotech reported sales revenue of €2.289 billion for the first nine months of 2026, up 4.3% as reported and 6.5% at constant currencies when customer tariff compensation is included. Excluding that compensation, operational sales growth at constant currencies was 7.8%. The company said recurring consumables remained the main growth driver, while bioprocess equipment also expanded.\n\nThe compensation affected how revenue was recorded. During the third quarter, Sartorius Stedim received refunds for U.S. levies invalidated by the Supreme Court and passed related tariff surcharges back to customers. The €28 million compensation after nine months was recognized as a reduction in sales revenue and cost of sales. With the surcharge and refund offsetting on a net basis, the company said they did not affect profitability.\n\nRegional sales also grew at constant exchange rates. EMEA revenue was €982 million, up 6.5%; the Americas generated €783 million, growing 7.6% excluding customer compensation and 3.9% including it; Asia-Pacific rose 10.6% to €524 million, with China contributing positively. The Americas comparison was particularly affected by tariff compensation, so the two growth rates describe different revenue bases.\n\nUnderlying EBITDA increased 4.8% to €716 million, and its margin rose from 31.1% to 31.3%. Sartorius Stedim attributed the improvement to positive volume effects and economies of scale more than offsetting product mix. Net profit rose 26.7% to €277 million; underlying net profit increased 9.4% to €350 million. These underlying measures are company-defined alternatives to standard financial measures.\n\nCash generation strengthened: operating cash flow advanced 11.6% to €498 million and free cash flow rose 58.5% to €264 million. The company linked operating cash flow to earnings and tariff refunds; lower investment spending also supported free cash flow. Capital expenditure was €232 million, or 10.1% of sales, compared with €276 million and 12.6% a year earlier. Net debt was €2.138 billion, with net debt to underlying EBITDA at 2.26.\n\nThe company reported 10,483 employees at 30 September, up from 10,265 at the end of 2025. It also introduced an improved single-use bioreactor bag designed to increase oxygen transfer, and added ready-to-use cytokines in closed sterile bags and an animal-component-free cell-culture medium for advanced therapies. These launches broaden the portfolio in bioprocessing and cell and gene therapy manufacturing.\n\nSartorius Stedim confirmed its full-year 2026 sales and profitability guidance and refined its capital-spending ratio. Revenue growth at constant currencies is expected at 6% to 10%; operational growth excluding tariff effects is expected near the midpoint, while growth including planned customer compensation is expected in the lower half. Compensation could reduce revenue by up to €35 million against initial assumptions. The underlying EBITDA margin is expected to be slightly above 31%.\n\nCapital expenditure is now projected at around 13% of revenue, and the net-debt-to-underlying-EBITDA ratio is expected to fall to slightly above 2. Management said forecasts use constant currencies and noted greater industry, geopolitical and trade-policy uncertainty. The figures cover nine months ending 30 September and include alternative performance measures; the company says these measures are not defined by international accounting standards and its release was unaudited.","title":"Sartorius Stedim reports nine-month sales and profit growth","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation"},{"api_url":"https://newsverum.com/api/v1/articles/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation?lang=en","language":"en","url":"https://newsverum.com/en/news/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation"},{"api_url":"https://newsverum.com/api/v1/articles/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation"},{"api_url":"https://newsverum.com/api/v1/articles/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation"},{"api_url":"https://newsverum.com/api/v1/articles/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation?lang=es","language":"es","url":"https://newsverum.com/es/news/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation"},{"api_url":"https://newsverum.com/api/v1/articles/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation?lang=de","language":"de","url":"https://newsverum.com/de/news/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation"},{"api_url":"https://newsverum.com/api/v1/articles/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation"}],"url":"https://newsverum.com/en/news/sartorius-stedim-nine-month-sales-profitability-and-tariff-compensation"},"version":"1"}